J&J: Q3 EPS of $0.09 Reflects One-Time Special Charge for Talc Litigation Resolution , Firefly Bio Acquisition, Sail Biomedicines Collaboration
J&J Q3 Stelara Worldwide Sales $716 Mln; Darzalex Worldwide Sales $4.24 Bln
J&J Q3 Sales $25.40 Bln VS Ibes Estimate $25.28 Bln
Johnson & Johnson Q3 EPS USD 0.09
Johnson & Johnson Q3 Sales USD 25,399 Million VS. Ibes Estimate USD 25,279 Million
LHT Holdings Limited Tender/ Acquisition/ Takeover/ Purchase Offer
United Malacca - Sept Palm Kernel Production 2,969 Tonnes
Binasat Communications - Proposes Private Placement of up to 60.4 Mln New Shares
Arch Capital Group Ltd. : Morgan Stanley Cuts to Equal-Weight From Overweight
INDIA'S SEBI: Adjudication Order in the matter of suspected insider trading in the scrip of Wipro Ltd
INDIA'S SEBI: Adjudication Order in the matter of inspection of IIFL Capital Services Limited
Southern Company : Bofa Global Research Cuts Price Objective to $92.00 From $100.00
Hyperscale Data - Decreases Atm Offering Amount to $100 Mln Under Sales Agreement - SEC Filing
Pershing Square Inc : Bofa Global Research Cuts to Underperform From Neutral Rating
Bbva - to Help Design Common Protocol Led by Sierra AI and Meta to Connect AI Agents With Businesses